Boston Scientific to Acquire Penumbra in $14.5 Billion Deal, Expanding Vascular Portfolio | MarketWire

Boston Scientific is acquiring Penumbra for $14.5 billion in a cash-and-stock deal, bolstering its vascular medicine business.